Listing 1 - 10 of 50 | << page >> |
Sort by
|
Choose an application
The study of medical history is interesting in itself and may help to modify the view sometimes expressed that medical students and doctors are lacking in culture of any sort. Moreover, some historical perspective is often advantageous when one is considering the multitude of advances that are now taking place in the theory and practice of medicine. This book, containing a series of collected papers concerning immunology and pathology and vascular biology and angiogenesis, drives us through scientific milestones in the history of medicine in the course of the past two centuries and highlights the contribution of pioneering scientists whose discoveries have paved the way to many researchers working in the fields of cell biology, developmental biology, immunology, pathology, and oncology. This book will serve as a resource for scientists, historians of medicine and philosophers of science and medicine.
Medicine -- History. --- Scientists -- History. --- Medicine --- Scientists --- History, Modern 1601 --- -Natural Science Disciplines --- Humanities --- History --- History, 20th Century --- History of Medicine --- History, 19th Century --- Science --- Disciplines and Occupations --- Oncology --- Health & Biological Sciences --- History. --- Medicine. --- Cancer research. --- Philosophy and science. --- Oncology. --- Biomedicine. --- Cancer Research. --- History of Medicine. --- Philosophy of Medicine. --- Philosophy of Science. --- Philosophy. --- Professional employees --- Oncology . --- Medicine-Philosophy. --- Tumors --- Normal science --- Philosophy of science --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Health Workforce --- Medicine—History. --- Medicine—Philosophy. --- Science and philosophy --- Cancer research --- Geschichte 1850-2010. --- Cancer. --- Cancer Biology. --- Cancers --- Carcinoma --- Malignancy (Cancer) --- Malignant tumors
Choose an application
Blood vessels of tumors display many structural and functional abnormalities. Their unusual leakiness, potential for rapid growth and remodelling, and expression of distinctive surface molecules mediate the dissemination of tumor cells in the bloodstream and maintain the tumor microenvironment. Like normal blood vessels, they consist of endothelial cells, mural cells and their enveloping basement membrane. Common features, irrespective of their origin, size and growth pattern, are absent hierarchy, formation of large-caliber sinusoidal vessels, markedly heterogeneous density, increased permeability, decreased and abnormal pericyte-endothelial cell adhesion, irregular basement membrane structure, and the incorporation of bone-marrow-derived endothelial progenitor cells in the microvasculature. A number of specific tumor endothelial markers have been identified, as well as chromosomal abnormalities. These markers may be used to deliver drugs specifically and selectively to the tumor microvasculature.
Cytology. --- Medicine. --- Oncology. --- Tumors -- Blood-vessels. --- Tumors --- Angiogenesis Modulating Agents --- Antineoplastic Agents --- Diseases --- Growth Inhibitors --- Blood Circulation --- Metaplasia --- Therapeutic Uses --- Growth Substances --- Pathologic Processes --- Cardiovascular Physiological Processes --- Pathological Conditions, Signs and Symptoms --- Physiological Effects of Drugs --- Cardiovascular Physiological Phenomena --- Pharmacologic Actions --- Circulatory and Respiratory Physiological Phenomena --- Chemical Actions and Uses --- Phenomena and Processes --- Chemicals and Drugs --- Neoplasms --- Microcirculation --- Angiogenesis Inhibitors --- Neovascularization, Pathologic --- Medicine --- Health & Biological Sciences --- Oncology --- Blood-vessels --- Microcirculation. --- Tumors. --- Tumours --- Cancer research. --- Cell biology. --- Biomedicine. --- Cancer Research. --- Cell Biology. --- Pathology --- Cysts (Pathology) --- Blood --- Circulation --- Oncology . --- Cell biology --- Cellular biology --- Biology --- Cells --- Cytologists --- Cancer research
Choose an application
The chick embryo chorioallantoic membrane (CAM) is an extraembryonic membrane which serves as a gas exchange surface and its function is supported by a dense capillary network. Because of its extensive vascularization and easy accessibility, the CAM has been broadly used to study the morpho-functional aspects of the angiogenesis process in vivo and to investigate the efficacy and mechanisms of action of pro-angiogenic and anti-angiogenic natural and synthetic molecules. The CAM is a suitable site for transplanting tissues, which can survive and develop in the CAM by peripheral anastomoses between graft and original CAM vasculature or by new angiogenic vessels grown from the CAM that invade the graft. While the formation of peripheral anastomoses between host and pre-existing donor vessels is the main, and the most common, mechanism involved in the revascularization of embryonic grafts, the growth of CAM-derived vessels into the graft is only stimulated in tumor grafts. The CAM has long been a favored system for the study of tumor angiogenesis and metastasis, because at this stage the chick immunocompetence system is not fully developed and the conditions for rejection have not been established. Tumors remain avascular for 72 h, after which they are penetrated by new blood vessels and begin a phase of rapid growth. Also, delivery of tumor cells onto the CAM allows the fine study of the effects of tumor derived angiogenic growth factors on blood vessel structure and functionality. The CAM may also used to verify the ability to inhibit the growth of capillaries by implanting tumors onto the CAM and by comparing tumor growth and vascularization with or without the administration of an anti-angiogenic molecule. Other studies using the tumor cells/CAM model have focused on the invasion of the chorionic epithelium and the blood vessels by tumor cells. The cells invade the epithelium and the mesenchymal connective tissue below, where they are found in the form of a dense bed of blood vessels, which is a target for intravasation.
Chickens -- Embryos. --- Metastasis -- Animal models. --- Metastasis. --- Neovascularization -- Animal models. --- Neovascularization. --- Neovascularization --- Metastasis --- Chickens --- Medicine --- Human Anatomy & Physiology --- Oncology --- Physiology --- Health & Biological Sciences --- Animal models --- Embryos --- Cancer --- Cancer metastasis --- Dissemination of cancer --- Metastases --- Metastatic cancer --- Neoplasm metastasis --- Spread of cancer --- Tumor dissemination --- Tumor metastasis --- Tumor spread --- Angiogenesis --- Dissemination --- Medicine. --- Cancer research. --- Oncology. --- Pathology. --- Cell biology. --- Biomedicine. --- Cancer Research. --- Cell Biology. --- Pathology --- Cancer invasiveness --- Cancer of unknown primary origin --- Blood-vessels --- Growth --- Oncology . --- Cytology. --- Cell biology --- Cellular biology --- Biology --- Cells --- Cytologists --- Disease (Pathology) --- Medical sciences --- Diseases --- Medicine, Preventive --- Tumors --- Cancer research
Choose an application
This book traces significant aspects of the history of immunology, exploring the immune system and immunodeficiency. The author recounts human hematopoietic development, and how a distinction of the immune system into thymus-dependent and thymus-independent components has been demonstrated in different animal species, including amphibians, birds, and mammals. Other themes explored in this book include discoveries about the role of the thymus of the Bursa of Fabricius in the development of immunologic competence, and observations on the changes in the lymphoid organs after bursectomy and thymectomy in chickens. Readers will discover how the bursa provides a unique microenvironment for the proliferation and differentiation of B cells, while thymectomized and irradiated animals were deficient in lymphocytes that mediated inflammatory responses, as assessed by skin graft rejection, delayed-type hypersensitivity, and graft versus host reaction. A clear perspective for understanding several diseases and also the entire lymphoid system emerges through the experiments and extensive histopathological studies of patients with primary immunodeficiency diseases that are described in these chapters. Researchers in the life sciences, in biomedicine and the history of medicine will all find something of value in this highly engaging work. It will also appeal to those with an interest in public health and neurobiology.
Medicine. --- Life sciences. --- Biomedicine. --- Biomedicine general. --- Medicine/Public Health, general. --- Life Sciences, general. --- Immune system. --- Thymus. --- Autoimmune diseases. --- Immunodeficiency. --- Immune deficiency --- Immunologic deficiency --- Immunological deficiency --- Autoimmunologic diseases --- Thymus gland --- Immunological system --- Immunity --- Immunosuppression --- Autoimmunity --- Immunologic diseases --- Endocrine glands --- Lymphoid tissue --- Anatomy --- Immunology --- Biosciences --- Sciences, Life --- Science --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Health Workforce --- Biomedicine, general.
Choose an application
This work describes the importance of tumor microenvironment in favouring tumor progression and angiogenesis. Under physiological conditions, angiogenesis is dependent on the balance of positive and negative angiogenic modulators within the vascular microenvironment and requires the functional activities of a number of molecules, including angiogenic factors, extracellular matrix proteins, adhesion molecules and proteolytic enzymes. In normal tissues, vascular quiescence is maintained by the dominant influence of endogenous angiogenesis inhibitors over angiogenic stimuli. Tumor angiogenesis is linked to a switch in the balance between positive and negative regulators, and mainly depends on the release by inflammatory or neoplastic cells of specific growth factors for endothelial cells, that stimulate the growth of the blood vessels of the host or the down-regulation of natural angiogenesis inhibitors. In particular, the inflammatory infiltrate may contribute to tumor angiogenesis, and there are many reports of associations between tumor inflammatory infiltrate, vascularity and prognosis. New therapeutic approaches have been developed with the aim to control tumor angiogenesis through targeting of different components of tumor microenvironment.
Oncology --- Medicine --- Health & Biological Sciences --- Tumors. --- Pathology, Cellular. --- Cellular pathology --- Cytopathology --- Neoplasms --- Tumours --- Pathology --- Cytodiagnosis --- Cysts (Pathology) --- Oncology. --- Oncology . --- Pathology. --- Cancer Research. --- Pharmacotherapy. --- Disease (Pathology) --- Medical sciences --- Diseases --- Medicine, Preventive --- Tumors --- Cancer research. --- Drug therapy --- Pharmacotherapy --- Therapeutics --- Drugs --- Pharmacology --- Cancer research
Choose an application
In 1971, J. Folkman published in the "New England Journal of Medicine" a hypothesis that tumor growth is angiogenesis-dependent. Folkman introduced the concept that tumors probably secrete diffusible molecules that could stimulate the growth of new blood vessels toward the tumor and that the resulting tumor neovascularization could conceivably be prevented or interrupted by angiogenesis inhibitors. Solid and haematological tumors consist of an avascular and a subsequent vascular phase. Assuming that this depends on the release of angiogenic factors, acquisition of angiogenic capability can be seen as an expression of progression from neoplastic transformation to tumor growth and metastasis. Beginning in the 1980's, the biopharmaceutical industry began exploiting the field of antiangiogenesis for creating new therapeutic compounds for modulating new blood vessels in tumor growth. In 2004, Avastin (Bevacizumab), a humanized anti-VEGF monoclonal antibody, was the first angiogenesis inhibitor approved by the Food and Drug Administration for the treatment of colorectal cancer. At present, it has been estimated that over 20,000 cancer patients worldwide have received experimental form of antiangiogenic therapy. This book offers a historical account of the relevant literature. It also emphasizes the crucial and paradigmatic role of angiogenesis as a biological process and the significance of antiangiogenic approach for the treatment of tumors.
Neovascularization inhibitors. --- Neovascularization. --- Tumors -- Blood-vessels -- Growth. --- Tumors. --- Tumors --- Neovascularization --- Neovascularization inhibitors --- Cardiovascular Physiological Processes --- Growth Inhibitors --- Metaplasia --- Metabolic Phenomena --- Antineoplastic Agents --- Growth Substances --- Diseases --- Science --- Physiological Effects of Drugs --- Pathologic Processes --- Therapeutic Uses --- Natural Science Disciplines --- Cardiovascular Physiological Phenomena --- Phenomena and Processes --- Pharmacologic Actions --- Circulatory and Respiratory Physiological Phenomena --- Disciplines and Occupations --- Pathological Conditions, Signs and Symptoms --- Chemical Actions and Uses --- Chemicals and Drugs --- Neoplasms --- Angiogenesis Inhibitors --- Angiogenesis Modulating Agents --- Neovascularization, Physiologic --- Neovascularization, Pathologic --- Research --- Metabolism --- Medicine --- Health & Biological Sciences --- Oncology --- Blood-vessels --- Growth --- Blood-vessels. --- Treatment. --- Cancer --- Tumours --- Medicine. --- History. --- Cancer research. --- Oncology. --- Pathology. --- Cell biology. --- Biomedicine. --- Cancer Research. --- History of Science. --- Cell Biology. --- Pathology --- Cysts (Pathology) --- Oncology . --- Cytology. --- Cell biology --- Cellular biology --- Biology --- Cells --- Cytologists --- Disease (Pathology) --- Medical sciences --- Medicine, Preventive --- Annals --- Auxiliary sciences of history --- Cancer research
Choose an application
This book is focused on the analysis of the role played by immune cell components in the angiogenic process associated with inflammation and tumor growth. Both innate and adaptive immune cells are involved in the mechanisms of endothelial cell proliferation, migration and activation, through the production and release of a large spectrum of pro-angiogenic mediators. These may create the specific microenvironment that favors an increased rate of tissue vascularization. The link between chronic inflammation and tumorigenesis was first proposed by Rudolf Virchow in 1863 after the observation that infiltrating leukocytes are a hallmark of tumors and first established a causative connection between the lymph reticular infiltrate at sites of chronic inflammation and the development of cancer. Tumors were described as wounds that never heal and surgeons have long described the tendency of tumors to recur in healing resection margin and it has been reported that wound healing environment provides an opportunistic matrix for tumor growth. As angiogenesis is the result of a net balance between the activities exerted by positive and negative regulators, this book will also provide information on some anti-angiogenic properties of immune cells that may be utilized for a potential pharmacological use as anti-angiogenic agents in inflammation as well as in cancer. The work is written for researchers in the field and also for graduate students which approach this matter. .
Medicine. --- Cancer research. --- Biomedicine. --- Cancer Research. --- Inflammation. --- Neovascularization. --- Angiogenesis --- Blood-vessels --- Inflammatory process --- Pathology --- Anti-inflammatory agents --- Growth --- Oncology. --- Tumors --- Cancer research
Choose an application
The aim if this book is to analyze the scientific biography of Judah Folkman, one of the most important scientist of the last century. More 50 years ago, Folkman found a revolutionary new way to think about cancer. Blood supply, Folkman hypothesized, was the key to tumor growth. Without new blood vessels, tumors simply did not thrive. In 1971, Folkman published his theory of angiogenesis in the “New England Journal of Medicine”. Angiogenesis, the formation and recruitment of new blood vessels, is necessary for tumor growth. Critics of the theory were silenced over time as Folkman and his colleagues reported the first purified angiogenic molecule, the first angiogenesis inhibitor and proposed the concept of angiogenic disease. The mechanism of angiogenesis is now a worldwide field of investigation. Over the years, Folkman and a growing team of researchers have isolated the proteins and unraveled the processes that regulate angiogenesis. Meanwhile, a new generation of angiogenesis research has emerged as well, widening the field into new areas of human disease and deepening it to examine the underlying biological processes responsible for those diseases.
Medicine. --- Cell biology. --- Biology --- Biomedicine. --- Biomedicine general. --- Cell Biology. --- History of Biology. --- History. --- Medical scientists --- Cancer --- Research. --- Folkman, M. Judah. --- Biomedical scientists --- Health scientists --- Life scientists --- Medical research personnel --- Cancer research --- Folkman, Judah --- Folkman, Moses Judah --- Cytology. --- Biology-History. --- Biology—History. --- Biomedicine, general. --- Health Workforce --- Cell biology --- Cellular biology --- Cells --- Cytologists
Choose an application
This book covers the most important aspects of Mast Cell Biology. It enables the reader to immerse in the new aspects of Mast Cells biology, which are no longer seen as an immunological effector cell, but a multi-functional efector cell. One which have roles that expands beyond the immunological realm and shows deep implications in the pathophysiology of several human disorders as well as transforming into a very important and promising target for therapy development in cancer, neurodegerative disorders, angiogenesis, inflammation and allergy. Across twelve chapter on Mast Cells Research, starting from the discovery and characterization of Mast Cells until the lastest findings and translational perspectives, the reader will get a complete view and a profound insight on the fundamental and applied aspects of Mast Cells Biology. The chapters are written in a clear and concise way in order to help navigating through complex biological scenarios. The author, Domenico Ribatti, Full professor of the University of Bari, is an expert in the field of Mast Cells with more than 800 publications.
Mast cells. --- Oncology. --- Immunology. --- Human genetics. --- Medicine. --- Cytology. --- Cancer Research. --- Human Genetics. --- Molecular Medicine. --- Cell Biology. --- Medicine/Public Health, general. --- Cell biology --- Cellular biology --- Biology --- Cells --- Cytologists --- Health Workforce --- Genetics --- Heredity, Human --- Human biology --- Physical anthropology --- Immunobiology --- Life sciences --- Serology --- Tumors --- Cancer research. --- Molecular biology. --- Cell biology. --- Molecular biochemistry --- Molecular biophysics --- Biochemistry --- Biophysics --- Biomolecules --- Systems biology --- Cancer research
Choose an application
Neovascularization. --- Tumors --- Growth. --- Cancer --- Neoplasm growth --- Tumor growth --- Blood-vessels --- Growth
Listing 1 - 10 of 50 | << page >> |
Sort by
|